The Quinolones inhibit bacteria by interacting with DNA topoisomerases (gyrases) of which four subunits (two A and B monomers) have been identified thus, inhibiting bacterial DNA gyrase. High level resistance to quinolones can be produced by serial exposure of bacteria to subinhibitory concentration. A Total of 408 suspected UTI and high vagina swab (HVS) samples were examined for bacteria and the isolates obtained tested against the newer quinolones. Prevalence of Bacterial isolates revealed Escherichia coli 110(92%) as the most isolated organism from urine, while Staphylococcus aureus 31(32%) was the most isolated species from HVS samples. Bacterial species such as coliforms 55(70%) and Klebsiella spp 42(84%), equally had high prevalence rate in urine samples. Pseudomonas aeroginosa 19(66%) was next to Staphylococcus aureus in terms of prevalence of isolated strains from HVS samples.The resistance pattern observed for these isolates, showed that the strains were least resistant to Ciprofloxacin, followed by Ofloxacin and Perfloxacin, while they were most resistant to Nalidixic acid. There was however no statistical significance (P<0.001) between the use of Ofloxacin and Perfloxacin, however, ANOVA showed a significant difference (P<0.05) between the pattern of Klebsiella spp resistance against Perfloxacin when compared to Proteus vulgaris.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.